Antiepileptogenesis after stroke—trials and tribulations: Methodological challenges and recruitment results of a Phase II study with eslicarbazepine acetate

There is currently no evidence to support the use of antiseizure medications to prevent unprovoked seizures following stroke. Experimental animal models suggested a potential antiepileptogenic effect for eslicarbazepine acetate (ESL), and a Phase II, multicenter, randomized, double‐blind, placebo‐co...

Descripción completa

Detalles Bibliográficos
Autores principales: Koepp, Matthias J., Trinka, Eugen, Mah, Yee‐Haur, Bentes, Carla, Knake, Susanne, Gigli, Gian Luigi, Serratosa, José M., Zelano, Johan, Magalhães, Luís M., Pereira, Ana, Moreira, Joana, Soares‐da‐Silva, Patrício
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Study Protocols
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472381/
https://www.ncbi.nlm.nih.gov/pubmed/36944588
http://dx.doi.org/10.1002/epi4.12735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472381/
https://www.ncbi.nlm.nih.gov/pubmed/36944588
http://dx.doi.org/10.1002/epi4.12735

Ejemplares similares